Blaser Brian J's Form 4 filing
QuidelOrtho CorpQDEL · filed Feb 13, 2026
- Accession no.
- 0001492289-26-000006
- Filed
- Feb 13, 2026
- Trade date
- Feb 13, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $248.6K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blaser Brian JCIK 0001492289 | Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Common Stock | PPurchaseAcquired | +10,540 | $23.59F1 | +$248,638.6 | 40,073 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The weighted average purchase price of these transactions was $23.5921 per share, with a range of $23.4200 to $23.9400 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.